NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market on Tuesday that its first-quarter revenues increased 45 percent, while it trimmed its net loss 30 percent.

The Redwood City, Calif.-based molecular diagnostics firm reported total revenues of $33.9 million compared to revenues of $23.4 million in the first quarter of 2008. All of the Q1 revenue, except for $469,000, came from sales of the firm's Oncotype DX breast cancer test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.